Novo Nordisk President and CEO Mike Doustdar: The era of oral formulations has arrived. With the approval of today's Wegovy® oral tablets, patients will have a convenient once-a-day pill that reduces weight as well as the original Wegovy® injections.

Novo Nordisk President and CEO Mike Doustdar: The era of oral formulations has arrived. With the approval of today's Wegovy® oral tablets, patients will have a convenient once-a-day pill that reduces weight as well as the original Wegovy® injections.